| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197566 α-galactosidase enzyme |
| 03/06/2001 | US6197565 α-Amylase variants |
| 03/06/2001 | US6197552 Efficient method by contacting 2'-deoxyribose-1-phosphoric acid or salt and 2,6-diaminopurine with microorganism or lysate which produces 2,6-diaminopurine-2'-deoxyriboside, then contacting with adenosine deaminase in aqueous medium |
| 03/06/2001 | US6197547 Trigger factor expression plasmids |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197525 Kit for detection of interleukin-17, interleukin-17 receptor, antagonists, or mimetics; includes receptor protein of defined amino acid sequence and a detecting reagent; for identifying immunosuppressants |
| 03/06/2001 | US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 03/06/2001 | US6197514 Amplification and detection of Yersinia enterocolitica |
| 03/06/2001 | US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease |
| 03/06/2001 | US6197297 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor |
| 03/06/2001 | CA1341197C Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use |
| 03/01/2001 | WO2001014567A1 Process for producing coenzyme q¿10? |
| 03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | WO2001014538A2 Plants with modified polyunsaturated fatty acids |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014533A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 03/01/2001 | WO2001014532A2 Alkaline bacillus amylase |
| 03/01/2001 | WO2001014526A1 Bacterial consortium ebc1000 and a method using the bacterial consortium ebc1000 for remedying biologically recalcitrant toxic chemicals contained in industrial wastewater, waste materials and soils |
| 03/01/2001 | WO2001014521A1 A method for decreasing the foam formation during cultivation of a microorganism |
| 03/01/2001 | WO2001014516A1 Astrocyte apparatus for bioprocessing a circulating fluid |
| 03/01/2001 | WO2001014419A2 Growth-enhancing media for mycobacteria |
| 03/01/2001 | WO2001014417A2 Pesticidal proteins |
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine |
| 03/01/2001 | WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000071579A3 Regulating organelle homeostasis in a cell factory |
| 03/01/2001 | WO2000061190A3 Treatment of intracellular infection |
| 03/01/2001 | WO2000049168A3 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |
| 03/01/2001 | CA2383397A1 Growth-enhancing media for mycobacteria |
| 03/01/2001 | CA2382693A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 03/01/2001 | CA2382468A1 A method for decreasing foam formation during cultivation of trichoderma |
| 03/01/2001 | CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | CA2382109A1 Astrocyte apparatus for bioprocessing a circulating fluid |
| 03/01/2001 | CA2348161A1 Process for producing coenzyme q10 |
| 03/01/2001 | CA2344469A1 Pesticidal proteins |
| 03/01/2001 | CA2315978A1 New nucleotide sequences coding for the thre gene and process for the enzymatic production of l-threonine using coryneform bacteria |
| 02/28/2001 | EP1078991A2 Methods for producing L-amino acids |
| 02/28/2001 | EP1078990A1 Natural, aliphatic and thiocarboxylic acids obtainable by fermentation and a microorganism therefore |
| 02/28/2001 | EP1078989A2 Method for producing L-glutamic acid by fermentation accompanied by precipitation |
| 02/28/2001 | EP1078082A1 Enzymatically-active recombinant human beta-tryptase and method of making same |
| 02/28/2001 | EP1078081A2 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 02/28/2001 | EP1078080A1 Methods for producing polypeptides in filamentous fungal mutant cells |
| 02/28/2001 | EP1078075A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 02/28/2001 | EP1078074A2 Mutant lactobacillus bulgaricus strains free from beta-galactoside activity |
| 02/28/2001 | EP1078069A2 Improved in vivo production of cephalosporins |
| 02/28/2001 | EP1078068A2 Polyhydroxyalkanoate biopolymer compositions |
| 02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078054A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 02/28/2001 | EP1078050A2 A vector for gene trap, and a method for gene trapping by using the vector |
| 02/28/2001 | EP1078006A1 Diagnosis and treatment of hepatic disorders |
| 02/28/2001 | EP1077983A2 Pria |
| 02/28/2001 | EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use |
| 02/28/2001 | EP0594710B1 Tyrosine kinase |
| 02/28/2001 | EP0576621B1 Ethanol production by recombinant hosts |
| 02/28/2001 | EP0548165B1 Expression of g protein coupled receptors in yeast |
| 02/28/2001 | CN1285875A Mutated hydroxy-phenyl pyruvate dioxygenase, DNA sequence and method for obtaining herbicide-tolerant plants containing such gene |
| 02/28/2001 | CN1285870A Novel pectate lyases |
| 02/28/2001 | CN1285869A Microorganism, method for obtaining same and feed additive |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/28/2001 | CN1285410A Process for producing leve diketone microbe |
| 02/28/2001 | CN1062605C Process for preparation of Escherichia coli vaccine |
| 02/27/2001 | US6194560 Synthetic escherichia coli gene which encodes lt-b; the dna sequence is optimized for plant codon usage; feeds; foods |
| 02/27/2001 | US6194549 Partially purified preparation of pen5, a glycoprotein pair; for detecting and/or removing natural killer cells from a mixed population of cells |
| 02/27/2001 | US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria |
| 02/27/2001 | US6194383 Homologous cyclic amino-acid sequences having different fatty acid residues synthesized by actinoplanes sp.; peptide antibiotics, lipopeptides a 1437, a-m, effective against grampositive bacteria and glycopeptide-resistant strains |
| 02/27/2001 | US6194203 Capable of undergoing at least 60 passages in culture due to expression of viral gene; expresses metabolic markers and metabolic differentiation markers for non-immortalized cells; drug, metabolic, and toxicity screening of intestinal cells |
| 02/27/2001 | US6194187 Apoptosis-inducing protein and gene encoding the same |
| 02/27/2001 | US6194183 Preparing polypeptide for use in surfactants; providing transformed phage, incubate with surfactants to deactivate polypeptide, separate phage that display variant polypeptides, isolated phage sequences of variant and determine sequence |
| 02/27/2001 | US6194181 Producing epothiolones in a culture medium by providing microorganisms such as myxobacteria which produce epothiolones, and adding a complex-forming agent soluble in the culture medium, such as cyclodextrins; antitumor agents |
| 02/27/2001 | US6194162 Method of screening for compounds that bind P2x receptor |
| 02/27/2001 | US6194140 HCV NS3 protein fragments having helicase activity and improved solubility |
| 02/27/2001 | US6193982 Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| 02/27/2001 | US6193964 Strain of streptomyces, and relevant uses thereof |
| 02/27/2001 | US6193963 Method of treating tumor-bearing patients with human plasma hyaluronidase |
| 02/27/2001 | CA2195784C Fumonisin-detoxifying enzymes |
| 02/27/2001 | CA2025598C Chimaeric hepadnavirus core antigen proteins |
| 02/27/2001 | CA2022177C Arginine deiminase, its manufacturing method, and an anti-cancer agent containing this enzyme as an effective ingredient |
| 02/27/2001 | CA1341192C Process for the preparation of a protein by yeasts using an inducible system, corresponding vectors and transformed strains |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/27/2001 | CA1341190C Process for the integration of a chosen gene into a chromosome of a bacteria, and bacteria obtained by the process |
| 02/25/2001 | CA2316526A1 Fermentative process for obtaining natural aromatic, aliphatic and thiocarboxylic acids and microorganism therefor |
| 02/22/2001 | WO2001012845A1 Screening for udp-glucose: glycoprotein glucosyltransferase (uggt) activity |
| 02/22/2001 | WO2001012833A2 Process for the biological production of 1,3-propanediol |
| 02/22/2001 | WO2001012826A2 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
| 02/22/2001 | WO2001012825A1 Herbicide-tolerant protoporphyrinogen oxidase |
| 02/22/2001 | WO2001012822A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 02/22/2001 | WO2001012821A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
| 02/22/2001 | WO2001012807A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 02/22/2001 | WO2001012797A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 02/22/2001 | WO2001012780A1 Microorganism secreting out lipid and process for producing the lipid and lipid balls having the lipid encapsulating therein by using the microorganism |